This episode of Pharma Pulse discusses a new executive order to build a domestic API stockpile, Eli Lilly’s 170% price ...

The integration aims to simplify access to Zepbound for eligible members while providing comprehensive, whole-person care to ...

This episode of Pharma Pulse explores AbbVie’s $195 million investment to expand US API production, new survey results ...

In the eighth part of this roundtable discussion, supply chain experts emphasize that effective manufacturing strategies depend on product type, market location, and regulatory complexity, requiring a ...

As over half of Americans now receive prescriptions through Medicare or Medicaid, pharma companies must shift from a commercial-first approach to a statutory-first model, making GTN governance a ...

The directive calls for building a six-month Strategic Active Pharmaceutical Ingredients Reserve, updating the essential ...

The US drug wholesaling industry is stable post-opioid settlement, with focus shifting to fund management and pharmacy ...

This episode of Pharma Pulse dives into Cardinal Health’s acquisition of Solaris Health to strengthen specialty services, how ...

This episode of Pharma Pulse covers Vinay Prasad’s return to lead the FDA’s biologics center after a brief resignation, new ...

In the first part of his Pharma Commerce video interview, Mark Lee, MarqVision’s founder and CEO, warns that counterfeiters ...

This episode of Pharma Pulse explores the FDA’s new proactive quality review initiative for drug manufacturing, GSK’s $370 ...

Pharma must align data, personalization, and cross-functional orchestration to deliver human-centered experiences that ...